Intravesical treatment of advanced urothelial bladder cancers with oncolytic HSV-1 co-regulated by differentially expressed microRNAs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intravesical treatment of advanced urothelial bladder cancers with oncolytic HSV-1 co-regulated by differentially expressed microRNAs

Published:2016-02-23 Issue:5 Volume:23 Page:460-468
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Zhang K-X,Matsui Y,Lee C,Osamu O,Skinner L,Wang J,So A,Rennie P S,Jia W W

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/gt201618.pdf

Reference47 articles.

1. Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10–29.

2. Porten SP, Cooperberg MR . High-risk nonmuscle invasive bladder cancer: definition and epidemiology. Curr Opin Urol 2012; 22: 385–389.

3. Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013; 63: 234–241.

4. Shah JB, McConkey DJ, Dinney CP . New strategies in muscle-invasive bladder cancer: on the road to personalized medicine. Clin Cancer Res 2011; 17: 2608–2612.

5. Dalbagni G . The management of superficial bladder cancer. Nat Clin Pract Urol 2007; 4: 254–260.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miRNA-Mediated Mechanisms in the Generation of Effective and Safe Oncolytic Viruses;Pharmaceutics;2024-07-25

2. Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy;Nature Protocols;2024-05-20

3. Role of human papillomavirus and associated viruses in bladder cancer: An updated review;Journal of Medical Virology;2023-09

4. Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1;Molecular Therapy - Oncolytics;2023-03

5. Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects;Journal of Clinical Medicine;2022-11-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3